Young woman with ductal breast cancer and bleeding gastric metastases
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Subtype
- Invasive Ductal Carcinoma
- Biomarkers
- ER-positive; PR-negative; HER2-negative
- Sex
- Female
- Spread to
- pancreas|liver|kidney|stomach
- Treatment
- surgery, chemotherapy, radiation, hormone therapy and palliative care
- Outcome
- In Memory
Treatment course, step by step
- Right mastectomy for node-positive breast cancer.
- Three cycles of adjuvant fluorouracil, epirubicin and cyclophosphamide.
- Four weekly cycles of nab-paclitaxel.
- Complete right axillary lymph node dissection after bulky adenopathy appeared, with 12 of 12 nodes positive.
- Radiation therapy to the right chest wall and lymph nodes.
- Adjuvant endocrine therapy attempted but poorly tolerated.
- Palliative care after rapid progression with gastric and multiorgan metastases.
What happened, in summary
A 31-year-old woman had node-positive invasive ductal cancer of the right breast that was oestrogen-receptor positive, progesterone-receptor negative and HER2 negative. She underwent right mastectomy, followed by three cycles of fluorouracil, epirubicin and cyclophosphamide and four weekly cycles of nab-paclitaxel. Seven months later, surveillance CT showed bulky right axillary lymph nodes without other visible distant disease. Complete axillary dissection found cancer in all 12 removed nodes. A repeat scan 1 month later showed new metastases in the pancreas, liver and kidney. She then received radiation to the right chest wall and lymph nodes, with endocrine therapy planned. Soon afterward, she developed 2 days of severe nausea, vomiting and an episode of frank haematemesis, accompanied by a substantial fall in haemoglobin. Endoscopy found multiple hard nodules with central ulceration across the upper stomach. Biopsy showed poorly differentiated adenocarcinoma with CK7, GATA3 and oestrogen-receptor positivity, consistent with metastatic ductal breast cancer rather than a new gastric primary. Endoscopic clips could not be placed because the nodules were firm, so haemostatic powder was used to reduce rebleeding. Endocrine therapy was attempted but poorly tolerated. With extensive disease and rapid clinical decline, she chose palliative care and died 1 month after the gastrointestinal bleeding presentation.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 4 Breast Cancer 295 stories
- Stage 4 ER Positive Breast Cancer 87 stories
- ER Positive Breast Cancer 242 stories
- Chemotherapy for ER Positive Breast Cancer 143 stories
- Chemotherapy for Breast Cancer 726 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer